Sader, H.S.; Castanheira, M.; Jones, M.E.; Mendes, R.E.
In Vitro Antimicrobial Activity of Ceftobiprole and Comparator Agents Against Streptococcus pneumoniae Responsible for Lower Respiratory Tract Infections in the United States (2016–2020), Including Resistant Subsets and Select Serotypes. Antibiotics 2026, 15, 375.
https://doi.org/10.3390/antibiotics15040375
AMA Style
Sader HS, Castanheira M, Jones ME, Mendes RE.
In Vitro Antimicrobial Activity of Ceftobiprole and Comparator Agents Against Streptococcus pneumoniae Responsible for Lower Respiratory Tract Infections in the United States (2016–2020), Including Resistant Subsets and Select Serotypes. Antibiotics. 2026; 15(4):375.
https://doi.org/10.3390/antibiotics15040375
Chicago/Turabian Style
Sader, Helio S., Mariana Castanheira, Mark E. Jones, and Rodrigo E. Mendes.
2026. "In Vitro Antimicrobial Activity of Ceftobiprole and Comparator Agents Against Streptococcus pneumoniae Responsible for Lower Respiratory Tract Infections in the United States (2016–2020), Including Resistant Subsets and Select Serotypes" Antibiotics 15, no. 4: 375.
https://doi.org/10.3390/antibiotics15040375
APA Style
Sader, H. S., Castanheira, M., Jones, M. E., & Mendes, R. E.
(2026). In Vitro Antimicrobial Activity of Ceftobiprole and Comparator Agents Against Streptococcus pneumoniae Responsible for Lower Respiratory Tract Infections in the United States (2016–2020), Including Resistant Subsets and Select Serotypes. Antibiotics, 15(4), 375.
https://doi.org/10.3390/antibiotics15040375
